STAT Therapeutics
STAT Therapeutics is focused on developing a drug- device combination for easy, rapid administration of intramuscular, life-saving medications by users in any setting, aiming to improve access and usability for acute emergency treatments such as pain, anaphylaxis, and seizures.
STAT Therapeutics
14064 Hayes Street, Overland Park, KS 66221
STAT Therapeutics is currently seeking investment
STAT Therapeutics is seeking a seed investment in the range of 1m-5m
What We Do
A device developed to facilitate immediate, accurate administration of injectable emergency medicines (e.g., opioids antagonists, anti-allergy, anti-epileptic drugs) into the dorsal forearm, enabling use by patients, caregivers, and healthcare professionals in various settings.
A device developed to facilitate immediate, accurate administration of injectable emergency medicines (e.g., opioids antagonists, anti-allergy, anti-epileptic drugs) into the dorsal forearm, enabling use by patients, caregivers, and healthcare professionals in various settings.
Application Area
Digital Health Technologies
Routes of Administration
Vaccines
FDA Regulated Medical Devices
Drugs
Infectious Diseases
Psychological and Cognitive Health and Performance
Battlefield Resuscitation
Key People
News & Updates
Presented research at the ASCPT 2025 Annual Meeting demonstrating the pharmacokinetics and safety of intramuscular naloxone administered via the dorsal forearm, supporting device development for this application.
Presented research at the ASCPT 2025 Annual Meeting demonstrating the pharmacokinetics and safety of intramuscular naloxone administered via the dorsal forearm, supporting device development for this application.